Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 6/20 | 0.69 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.69 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.62 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14825312 | 1.00 | AHCY (0.69) | AHCYADORA2BADORA3YTHDC1ADORA1 | |
| SCHEMBL26381999 | 0.84 | AHCY (0.73) | AHCYADORA2BADORA3 | |
| SCHEMBL10677199 | 0.83 | AHCY (0.73) | AHCYADORA2BADORA3ADORA1 | |
| SCHEMBL10677210 | 0.83 | AHCY (0.73) | AHCYADORA2BADORA3ADORA1 | |
| SCHEMBL11161958 | 0.83 | AHCY (0.75) | AHCYADORA2BADORA3 | |
| SCHEMBL30462347 | 0.83 | AHCY (0.75) | AHCYADORA2BADORA3 | |
| Aristeromycin SCHEMBL7534801 | 0.81 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL14515457 | 0.81 | AHCY (1.00) | AHCYADORA2B | |
| Aristeromycin SCHEMBL10353292 | 0.81 | AHCY (1.00) | AHCYADORA2B | |
| SCHEMBL11162110 | 0.81 | AHCY (0.73) | AHCYADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130085133-A1 | ANTI-VIRAL TREATMENT AND ASSAY TO SCREENFOR ANTI-VIRAL AGENT | Sourthern Research Institute Office of Commercialization and Intellectual Prop. (US) | 2013-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085133-A1 | ANTI-VIRAL TREATMENT AND ASSAY TO SCREENFOR ANTI-VIRAL AGENT | MAVS, SNRPE, LONP1 | AHCY 2783/4885ADORA2B 3886/4885ADORA3 4121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.